257 related articles for article (PubMed ID: 34324588)
1. Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma.
Chang FC; Wong TT; Wu KS; Lu CF; Weng TW; Liang ML; Wu CC; Guo WY; Chen CY; Hsieh KL
PLoS One; 2021; 16(7):e0255500. PubMed ID: 34324588
[TBL] [Abstract][Full Text] [Related]
2. Texture Analysis of T1-Weighted Contrast-Enhanced Magnetic Resonance Imaging Potentially Predicts Outcomes of Patients with Non-Wingless-Type/Non-Sonic Hedgehog Medulloblastoma.
Li J; Chen C; Fu R; Zhang Y; Fan Y; Xu J; Cen Y
World Neurosurg; 2020 May; 137():e27-e33. PubMed ID: 31589984
[TBL] [Abstract][Full Text] [Related]
3. Machine-learning approach to predict molecular subgroups of medulloblastoma using multiparametric MRI-based tumor radiomics.
Saju AC; Chatterjee A; Sahu A; Gupta T; Krishnatry R; Mokal S; Sahay A; Epari S; Prasad M; Chinnaswamy G; Agarwal JP; Goda JS
Br J Radiol; 2022 Jun; 95(1134):20211359. PubMed ID: 35262407
[TBL] [Abstract][Full Text] [Related]
4. MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.
Iv M; Zhou M; Shpanskaya K; Perreault S; Wang Z; Tranvinh E; Lanzman B; Vajapeyam S; Vitanza NA; Fisher PG; Cho YJ; Laughlin S; Ramaswamy V; Taylor MD; Cheshier SH; Grant GA; Young Poussaint T; Gevaert O; Yeom KW
AJNR Am J Neuroradiol; 2019 Jan; 40(1):154-161. PubMed ID: 30523141
[TBL] [Abstract][Full Text] [Related]
5. MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
Zhang M; Wong SW; Wright JN; Wagner MW; Toescu S; Han M; Tam LT; Zhou Q; Ahmadian SS; Shpanskaya K; Lummus S; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Lober RM; Cho YJ; Ertl-Wagner B; Ho CY; Mankad K; Vogel H; Cheshier SH; Jacques TS; Aquilina K; Fisher PG; Taylor M; Poussaint T; Vitanza NA; Grant GA; Pfister S; Thompson E; Jaju A; Ramaswamy V; Yeom KW
Radiology; 2022 Aug; 304(2):406-416. PubMed ID: 35438562
[TBL] [Abstract][Full Text] [Related]
6. Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma.
Yan J; Liu L; Wang W; Zhao Y; Li KK; Li K; Wang L; Yuan B; Geng H; Zhang S; Liu Z; Duan W; Zhan Y; Pei D; Zhao H; Sun T; Sun C; Wang W; Hong X; Wang X; Guo Y; Li W; Cheng J; Liu X; Ng HK; Li Z; Zhang Z
Front Oncol; 2020; 10():558162. PubMed ID: 33117690
[TBL] [Abstract][Full Text] [Related]
7. MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features.
Zheng H; Li J; Liu H; Ting G; Yin Q; Li R; Liu M; Zhang Y; Duan S; Li Y; Wang D
J Magn Reson Imaging; 2023 Jul; 58(1):236-246. PubMed ID: 36412264
[TBL] [Abstract][Full Text] [Related]
8. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R
Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271
[TBL] [Abstract][Full Text] [Related]
10. Radiomics-based machine learning models for prediction of medulloblastoma subgroups: a systematic review and meta-analysis of the diagnostic test performance.
Karabacak M; Ozkara BB; Ozturk A; Kaya B; Cirak Z; Orak E; Ozcan Z
Acta Radiol; 2023 May; 64(5):1994-2003. PubMed ID: 36510435
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
12. Implications of tumor location on subtypes of medulloblastoma.
Teo WY; Shen J; Su JM; Yu A; Wang J; Chow WY; Li X; Jones J; Dauser R; Whitehead W; Adesina AM; Chintagumpala M; Man TK; Lau CC
Pediatr Blood Cancer; 2013 Sep; 60(9):1408-10. PubMed ID: 23512859
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.
Chinnam D; Saraswati A; Jogunoori S; Verma A; Kiran T; Salunke P; Gupta N; Kumar N; Madan R; Radotra BD; Gupta K
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):561-568. PubMed ID: 37471625
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.
Narayan V; Sugur H; Jaiswal J; Arvinda HR; Arivazhagan A; Somanna S; Santosh V
Pediatr Neurosurg; 2019; 54(5):329-340. PubMed ID: 31480064
[TBL] [Abstract][Full Text] [Related]
15. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
[TBL] [Abstract][Full Text] [Related]
16. MRI surrogates for molecular subgroups of medulloblastoma.
Perreault S; Ramaswamy V; Achrol AS; Chao K; Liu TT; Shih D; Remke M; Schubert S; Bouffet E; Fisher PG; Partap S; Vogel H; Taylor MD; Cho YJ; Yeom KW
AJNR Am J Neuroradiol; 2014 Jul; 35(7):1263-9. PubMed ID: 24831600
[TBL] [Abstract][Full Text] [Related]
17. Low Expression of the
de Araújo MA; Malafaia O; Ribas Filho JM; Fratini L; Roesler R; Isolan GR
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511358
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
19. Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma.
Aras Y; Dölen D; İribas Çelik A; Kılıç G; Kebudi R; Ünverengil G; Sabancı PA; İzgi AN
Childs Nerv Syst; 2021 Dec; 37(12):3733-3742. PubMed ID: 34550414
[TBL] [Abstract][Full Text] [Related]
20. Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.
Li Y; Jiang T; Shao L; Liu Y; Zheng C; Zhong Y; Zhang J; Chang Q
J Neurooncol; 2016 Sep; 129(3):423-431. PubMed ID: 27406588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]